In The News
Stay informed with the latest research breakthroughs, treatment updates, and community stories related to Parkinson’s disease.
Eye-movement biomarkers may flag Parkinson’s decline earlier
Company data link subtle eye changes to later declines in daily functioning Written by Andrea Lobo | Aug. 17, 2026 Eye-movement biomarkers may flag functional decline before standard assessments. Parkinson's can cause slower, less accurate eye movements as the disease...
Exploring Genetic Differences in Parkinson’s Disease by Ancestry
By Olivia Dimmer – Aug 4, 2026 - Northwestern Medicine A landmark international study has found that the genetic drivers of Parkinson’s disease can vary dramatically between populations, underscoring the need to include people of various ancestries in genetic research...
More activity linked to slower motor, cognitive decline in Parkinson’s
Benefits appeared to involve mechanisms beyond preserving dopamine function Written by Patricia Inácio, PhD | Aug. 18, 2026 More physical activity was linked to slower decline in certain motor and cognitive measures and caudate DAT availability. Greater activity was...
Improving Parkinson’s disease treatment
August 11, 2026 - National Institutes of Health At a Glance Researchers identified a drug candidate that enhanced effectiveness and reduced side effects of the standard Parkinson’s disease treatment in animal models. If the drug candidate proves effective in people,...
Gut bacteria can vary with Parkinson’s severity, age, and medications
Study findings could help guide new treatment approaches Written by Margarida Maia, PhD | Aug. 18, 2026 Parkinson's disease is linked to specific alterations in gut bacterial communities that differ from healthy individuals. These microbial variations are closely...
Living near dry cleaners linked to higher Parkinson’s odds in older adults
Study found a dose-response pattern, with the highest odds within 500 feet Written by Margarida Maia, PhD | Aug. 11, 2026 Living near dry cleaners was associated with higher Parkinson’s odds in adults age 67 and older. The association was strongest among those living...
Ready to use Parkinson’s stem cell therapy put on FDA fast track
In trial, treatment showed benefits in those with early-onset disease Written by Margarida Maia, PhD | Aug. 10, 2026 The U.S. Food and Drug Administration has awarded fast track status to an experimental stem cell therapy for Parkinson's disease. XS411 is a...
Road Traffic Noise Linked to Higher Parkinson Disease Risk
27 Jul 2026 American Medical Journal - Neurology - Author: Katrina Thornber Key Summary: A Danish cohort study of 3,103,577 people examined road traffic noise and Parkinson disease risk. Higher noise exposure was linked to increased PD risk (HR 1.03–1.06 across...
Parkinson’s therapy reduces disease biomarkers in 12-week trial
Alpha-synuclein, inflammation, nerve health markers lowered with risvodetinib Written by Patricia Inácio, PhD | Aug. 7, 2026 Risvodetinib is an oral experimental therapy being developed to treat Parkinson’s disease and address underlying cellular damage. A 12-week...
Ozone air pollution exposure may increase Parkinson’s risk: Study
Finnish health register data tracks air quality across decades Written by Marisa Horak, MS | Aug. 6, 2026 Long-term exposure to ozone air pollution may increase the risk of developing Parkinson’s disease. Animal studies suggest ozone exposure can trigger brain damage...